市场调查报告书
商品编码
1423014
2024-2032 年按产品类型(眼科黏弹性装置、人工水晶体、飞秒雷射、超音波乳化设备等)、最终用途和地区分列的白内障手术器械市场报告Cataract Surgical Devices Market Report by Product Type (Ophthalmic viscoelastic devices, Intraocular lenses, Femtosecond laser, Phacoemulsification equipment, and Others), End-Use, and Region 2024-2032 |
2023年全球白内障手术器械市场规模达89亿美元。展望未来, IMARC Group预计到2032年市场规模将达到124亿美元,2024-2032年复合年增长率(CAGR)为3.7%。白内障病例数量的不断增加、飞秒雷射和超音波乳化系统等先进设备的引入、全球医疗保健支出的不断增长以及医疗保健服务的改善是推动市场发展的一些关键因素。
白内障手术器械是指白内障手术期间使用的一系列专用仪器和设备,白内障手术是一种常见的外科手术,用于从眼睛中摘除浑浊的晶状体(白内障)并用人工晶状体(IOL)替换。白内障会导致视力障碍甚至失明,而白内障手术是恢復视力、提升患者生活品质的有效方法。白内障手术器械在确保以最小的风险和改善的结果成功进行白内障手术方面发挥着至关重要的作用。科技的进步促进了复杂设备的发展,彻底改变了白内障手术,使其成为全球最常见和最成功的外科手术之一。
在行业的几个关键驱动因素和趋势的推动下,市场正在经历显着成长。白内障手术设备的技术进步在推动市场成长方面发挥了关键作用。飞秒雷射辅助白内障手术和先进人工水晶体材料等创新提高了手术精度,带来更好的结果和更快的患者康復时间。此外,人们对眼睛健康意识的增强和先进治疗方案的可用性正在影响患者的偏好。现在,患者更愿意在病情早期接受白内障手术,以维持生活品质和视力。因此,对高品质白内障手术的需求不断增长,推动了白内障手术设备的市场成长。此外,亚洲、拉丁美洲和非洲的新兴经济体对白内障手术设备的需求正在激增,这主要是由于医疗基础设施的改善、可支配收入的增加以及人们对眼睛健康意识的增强。随着医疗保健设施的改善,越来越多的患者寻求白内障手术,促进了全球市场的扩张。
白内障盛行率不断上升,老年人口不断增加
全球人口老化是影响市场的主要因素之一。随着年龄的增长,罹患白内障的风险显着增加。白内障是一种常见的与年龄相关的眼部疾病,其特征是眼睛的自然水晶体混浊,导致视力模糊和视力下降。随着世界人口的寿命比以往任何时候都长,被诊断出患有白内障的人数正在增加。因此,对白内障手术和相关手术设备的需求不断增长。老年人寻求有效且安全的治疗方案以恢復视力并提高整体生活品质。这种人口结构的变化刺激了製造商在研发方面的大量投资,从而推出了先进的白内障手术设备,这些设备可以提供更好的结果、更短的恢復时间并提高患者满意度。
各种技术进步
白内障手术设备的持续技术进步和创新彻底改变了眼科领域。这些创新在推动市场成长方面发挥了关键作用。製造商不断探索新材料、设计和手术技术,以提高白内障手术的效率和安全性。一项重大进步是飞秒雷射辅助白内障手术 (FLACS) 的引入,它在手术过程中提供精确且可重复的切口。 FLACS 使外科医生能够以更高的准确性执行白内障手术的各个步骤,最大限度地降低併发症的风险并改善视力结果。此外,优质人工水晶体(IOL)的开发扩大了白内障患者的治疗选择。高级人工水晶体具有多焦点、扩展焦深和散光矫正等功能,使患者无需依赖眼镜即可在不同距离获得清晰的视力。
新兴经济体的需求不断增加
新兴经济体对白内障手术器械的需求不断增长是影响市场的另一个重要因素。随着亚洲、拉丁美洲和非洲国家医疗基础设施的改善和可支配收入的增加,白内障手术的可近性也增加。随着人们对眼睛健康的认识不断提高以及医疗设施的普及,越来越多的人正在寻求白内障治疗。此外,这些地区的政府和医疗机构正在积极推动眼部健康措施并提供白内障手术补贴,以解决白内障引起的视力障碍的负担。这种积极主动的方法不仅增加了手术数量,还促进了先进白内障手术设备的采用。
The global cataract surgical devices market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The growing number of cataract cases, the introduction of sophisticated devices, such as femtosecond lasers and phacoemulsification systems, the growing global healthcare expenditure and the improved access to healthcare services represent some of the key factors driving the market.
Cataract surgical devices refer to a range of specialized instruments and equipment used during cataract surgery, a common surgical procedure to remove a cloudy lens (cataract) from the eye and replace it with an artificial intraocular lens (IOL). Cataracts can cause vision impairment or blindness, and cataract surgery is an effective method to restore vision and improve the quality of life for patients. Cataract surgical devices play a vital role in ensuring successful cataract surgeries with minimal risk and improved outcomes. Advances in technology have led to the development of sophisticated devices that have revolutionized cataract surgery, making it one of the most common and successful surgical procedures globally.
The market is experiencing significant growth, driven by several key drivers and trends in the industry. Technological advancements in cataract surgical devices have played a pivotal role in propelling market growth. Innovations such as femtosecond laser-assisted cataract surgery and advanced IOL materials have improved surgical precision, leading to better outcomes and quicker patient recovery times. Moreover, the increasing awareness of eye health and the availability of advanced treatment options are influencing patient preferences. Patients are now more willing to undergo cataract surgery at an earlier stage of the condition to maintain their quality of life and visual acuity. Consequently, the rising demand for high-quality cataract surgical procedures is bolstering the market growth of cataract surgical devices. Besides, the emerging economies in Asia, Latin America, and Africa are witnessing a surge in demand for cataract surgical devices, primarily due to improving healthcare infrastructure, rising disposable incomes, and growing awareness about eye health. As access to healthcare facilities improves, a larger patient pool seeks cataract surgery, contributing to the expansion of the global market.
Growing prevalence of cataract and rising geriatric population
The aging global population is one of the primary factors impacting the market. As people age, the risk of developing cataracts increases significantly. Cataracts are a common age-related eye condition characterized by the clouding of the eye's natural lens, leading to blurred vision and decreased visual acuity. With the world's population living longer than ever before, the number of individuals diagnosed with cataracts is on the rise. As a result, there is a growing demand for cataract surgeries and related surgical devices. The elderly population seeks effective and safe treatment options to restore their vision and improve their overall quality of life. This demographic shift has spurred significant investments in research and development by manufacturers, leading to the introduction of advanced cataract surgical devices that offer better outcomes, shorter recovery times, and enhanced patient satisfaction.
Various technological advancements
Continuous technological advancements and innovations in cataract surgical devices have revolutionized the field of ophthalmology. These innovations have played a pivotal role in driving market growth. Manufacturers are constantly exploring new materials, designs, and surgical techniques to enhance the efficiency and safety of cataract surgeries. One significant advancement is the introduction of femtosecond laser-assisted cataract surgery (FLACS), which provides precise and reproducible incisions during the procedure. FLACS enables the surgeon to perform various steps of cataract surgery with increased accuracy, minimizing the risk of complications and improving visual outcomes. Additionally, the development of premium intraocular lenses (IOLs) has expanded treatment options for cataract patients. Premium IOLs offer features such as multifocality, extended depth of focus, and astigmatism correction, allowing patients to achieve clear vision at different distances without relying on glasses.
Increasing demand in emerging economies
The growing demand for cataract surgical devices in emerging economies is another significant factor influencing the market. As healthcare infrastructure improves and disposable incomes rise in countries across Asia, Latin America, and Africa, the accessibility of cataract surgeries has increased. With greater awareness of eye health and improved access to medical facilities, more individuals are seeking treatment for cataracts. Furthermore, governments and healthcare organizations in these regions are actively promoting eye health initiatives and offering subsidized cataract surgeries to tackle the burden of visual impairment caused by cataracts. This proactive approach has not only boosted the number of surgeries performed but also fostered the adoption of advanced cataract surgical devices.
IMARC Group provides an analysis of the key trends in each segment of the global cataract surgical devices market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type and end-use.
Ophthalmic viscoelastic devices (OVDs)
Intraocular lenses (IOLs)
Femtosecond laser
Phacoemulsification equipment
Others
Intraocular lenses represent the most popular product type
The report has provided a detailed breakup and analysis of the market based on the product type. This includes ophthalmic viscoelastic devices (OVDS), intraocular lenses (IOLs), femtosecond laser, phacoemulsification equipment, and others. According to the report, intraocular lenses represented the largest segment.
Intraocular lenses are a crucial component of cataract surgery, as they play a pivotal role in restoring vision after the cloudy natural lens has been removed. Cataracts cause significant visual impairment, and IOLs offer an effective and reliable solution to replace the clouded lens with an artificial one, allowing patients to regain clear vision. Moreover, the field of intraocular lenses has witnessed significant technological advancements over the years. Manufacturers have continually improved the design and materials used in IOLs to enhance optical performance and patient comfort. For example, the introduction of multifocal and extended depth of focus IOLs allows individuals to achieve clear vision at various distances, reducing the reliance on glasses post-surgery.
Hospitals
Eye care clinics
Eye Treatment and Surgical Centres
Hospitals hold the largest market share
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, eye care clinics, and eye treatment and surgical centers. According to the report, hospitals hold the largest market share.
Hospitals are equipped with advanced surgical facilities and a skilled team of ophthalmic surgeons who specialize in cataract surgery. Cataract surgery is a delicate procedure that requires precision and expertise, and hospitals are well-equipped to provide the necessary resources and personnel to perform these surgeries effectively. Moreover, hospitals offer comprehensive eye care services, making them a go-to choice for patients seeking cataract treatment. From pre-operative evaluations and diagnostics to post-operative follow-ups, hospitals provide all-inclusive care, ensuring the best possible outcomes for patients undergoing cataract surgery. Apart from this, many ophthalmologists and eye care specialists practice in hospitals. These professionals refer patients with cataracts to their affiliated hospitals for surgical procedures, further boosting the hospitals' market share in the market.
Europe
North America
Latin America
Asia Pacific
Middle East and Africa
North America accounts for the majority of market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America, particularly the United States, has a significant aging population. With age being a primary risk factor for cataracts, the region experiences a higher prevalence of cataract cases. As a result, there is a substantial demand for cataract surgeries and related surgical devices, driving the market share in the region. Besides, North America boasts a well-developed and advanced healthcare infrastructure with a wide network of hospitals, ambulatory surgical centers (ASCs), and specialty eye clinics. This infrastructure facilitates easy access to cataract surgeries, making them more readily available to patients. The availability of state-of-the-art medical facilities and skilled ophthalmic surgeons contributes to the region's higher market share.
The competitive landscape of the market is characterized by the presence of several established medical device companies, along with emerging players, striving to gain a foothold in the industry. Nowadays, key players are offering a wide array of cataract surgical devices, including different types of intraocular lenses (IOLs) with varying features (multifocal, toric, and accommodating), phacoemulsification systems, and other surgical instruments. They are also expanding their market presence by entering new geographic regions and establishing partnerships with local distributors and healthcare facilities. Besides, to maintain credibility and gain the trust of patients and healthcare providers, key players are ensuring strict adherence to international regulatory standards and obtain necessary certifications for their products.
Abbott Laboratories
Hoya Corporation
Carl Zeiss Meditec AG
Alcon Laboratories Inc.
Essilor International S.A.
In January 2021, Alcon launched AcrySof IQ Vivity, the first and only non-diffractive extended depth of focus intraocular lens in the United States to demonstrate their ongoing commitment to growing IOL portfolio and delivering differentiated innovations that meet surgeon and patient needs.
In October 2020, HOYA Surgical Optics announces global launch of CLEARlog - an app designed to analyze clinical outcomes of Cataract and RLE surgery. It is an app that allows surgeons to record and analyze their cataract and RLE practice patterns.
Carl Zeiss Meditec acquired IanTECH for an undisclosed amount. The acquisition strengthened Carl Zeiss' position in the cataract surgery portfolio as IanTECH focuses on technology solutions for micro-interventional cataract surgery.